Stay ConnectedPodcast interviews with genius-level (top .1%) practitioners, scientists, researchers, clinicians and professionals in Cancer, 3D Bio Printing, CRISPR-CAS9, Ketogenic Diets, the Microbiome, Extracellular Vesicles, and more.
Subscribe today for the latest medical, health and bioscience insights from geniuses in their field(s).
Copyright: © Richard Jacobs
WTZ Blockchain College is currently the second largest blockchain content producer in China, with over 26,000 online views per day. They are focused on delivering the guts and glory of the industry with stories on all things blockchain. Co-Founder, Xueyuan She, shares the fascinating story of WTZ, the founder of WTZ Blockchain College and how it all began. WTZ, (the person, not the company), was a college drop-out, just looking to start a successful business like anyone would. Long story short, that venture didn't pan out and so he began a journey of couch-surfing and self discovery. Soon enough, WTZ had accumulated some wealth and started investing in cryptocurrency. Before he knew it, he had made some healthy earnings. He then started a diary and record of what the crypto was doing and later decided to publish it. Of this great idea, WTZ Blockchain College was born. Recently they also added video content, where viewers send in footage and it is published and provides a platform for comments. WTZ College has come a long way from the couch surfing, diary days. Today they now rank as one of the top content producers of crypto insider info in China sharing tips and suggestions on investment strategies, first hand feedback from bitcoin miners, war-stories from beyond the crypto grave and more.
Starta Capital is providing unparalleled access to the venture capital market by creating a unique VC fund that will allow outside unaccredited investors to co-invest in Eastern European tech companies that show potential for success. According to managing partner Serge Milman, Starta Capital is creating a hybrid capital fund to provide opportunities for smaller investors that cannot afford the traditionally high cost of VC investments. By partnering with Starta Capital, investors will have greater VC opportunities and also benefit from the unique accelerator program that provides funding, coaching, and development of companies fully vetted by Starta Capital. In addition, Starta Capital relies on blockchain technology to provide investors with unprecedented transparency, security, and liquidity. According to Milman, blockchain is changing the VC industry and he is "proud" that Starta Capital is working to "achieve that future sooner than later."
The primary goal of BlockCAT is to provide access to easy to use smart contracts on the Ethereum blockchain and bring blockchain technology to the mainstream. According to CEO Eric Huang, the BlockCAT website allows anyone to create, manage, and deploy smart contracts with no programming knowledge or expertise necessary.Smart contracts provide unique and powerful capabilities and BlockCAT provides a decentralized web platform to allow users to customize smart contracts. Users chose pre-build contracts and provide information that is used to create a smart contract in only a few steps.The BlockCAT platform will evolve as more contracts are available and eventually invite third-party blockchain developers to contribute which will lead to more uniformity and standardization. In addition, BlockCAT hopes to provide solutions to common problems such as reducing the risk of lost coins, simplifying airdrops, and splitting accounts. Huang and his team at BlockCAT are dedicated to finding easy to use solutions to current cryptocurrency users and to provide new users with access to smart contracts.
The business of anti-aging has been the focus for scientists and anyone with a gray hair, for as long as we all can remember. Daily in magazines and on television, we are bombarded with buzzwords like free radicals, anti-aging, inflammation, preserving, skin-repair and so on. There are numerous companies all over the world dedicated to curing everything from cancer to wrinkles. Rather than focus on a specific ailment, AgeX Therapeutics, a biotechnology company formed in 2017, puts the spotlight on aging itself as the "disease". CEO Michael West, sits down to share his vision for AgeX, as they work on developing solutions, using powerful regenerative treatments to combat aging and its effects on the human body. He also weighs in on the compelling scientific advancements that have come along in the past 10-15 years in this field. Researchers are now starting to unify on what aging is and are forming a biology, so to speak. This allows like-minded folks to pool resources, ideas, energy and their scientific minds to solve the significant unmet needs in the age-related disease market.
EpiBiome, a microbiome engineering company based in San Francisco, is busy developing next generation antibacterials to fight a real problem; the growing threat of antibiotic resistant bacteria. Their focus is also on engineering the human microbiome using technology called"phages", or bacteria-specific viruses. These "phages" are natural enemies of bacteria, essentially injecting it with the flu and killing it. They then go on to attach to other bacteria and do the same. Bacteriophages, or "phages" for short, have been around for a billion years and are still an effective evolutionary battle around today. EpiBiome is working to get these FDA-approved alternatives to traditional antibiotics, by using phage mixtures that will target and destroy known pathogens which have been formulated into a treatment for a specific indication. EpiBiome's wide focus is not only on agriculture and human health, but also they have cast a wide net on solving the same issues in clean water development, aquaculture and food safety. Nick Conley, now Chief Science Officer, sits down to explain the critical importance of finding innovative ways to combat antibiotic resistant bacteria and the threat it poses on our future.
The problem: Data in the life sciences field is outdated. Methods are archaic and expensive or inaccurate. Old models of data gathering and interpretations in the health sciences industries just simply don't work any longer. These fields are calling for change. Solution: Enter Innoplexus. Innoplexus, established in 2011 and is a leading provider of Artificial Intelligence products, aiming to overcome the data and talent challenges in life sciences and the AI fields. Gunjan Bhardwaj, CEO & Co-Founder of Innoplexus, sits down with us to offer his insights into leveraging data and AI to better the future of healthcare. The goal was to provide an automated Data as a Service model, to increase access to accurate data at more reasonable pricing for the purpose of decision making in these important fields. Bhardwaj says part of the goal of Innoplexus is to make the data easily accessible and easily understood for researchers. He believes this technology will change the way problems and challenges in the life sciences field are solved by offering instant access to current and accurate research findings. In the end, the goal is to aid in the development and findings of faster, less expensive and better quality therapies to many health issues.
The majority of research on the cause and treatment of ageing-related diseases has focused on the role of DNA in the ageing process. However, this area of research has proven to be one of the most difficult, and only a limited amount of progress has been made. What if the answer doesn't lie in DNA at all? This is the question that David Grainger set out to investigate when he founded Methuselah Health in 2014. Rather than focusing on the role of DNA in the ageing process, the researchers at Methuselah are looking at the role of proteins. Grainger explains that since proteins have the ability to repair damaged DNA, understanding the mechanism of protein damage and the effects of the accumulation of damaged proteins in the body may be the real key to mitigating the progression of ageing-related diseases, such as Alzheimer's. As the world's first quantitative platform for measuring protein damage, Methuselah is a pioneer in this emerging and exciting field of research. To find out more, visit methuselah-health.com.
Getting involved in the crypto space requires familiarity with certain technical terms, the ability to navigate advanced technology, and some experience with finance. For many people, that combination is overwhelming and discouraging. This is what Tu Doan set out to change when he founded Stack, a cryptocurrency investing platform designed with one primary goal: to attract more people to the world of cryptocurrency by streamlining and simplifying the process of participating in it. It's simple: just sign up, link your bank account or credit card to the app, and go about your day. With every purchase that you make, Stack will invest your spare change in cryptocurrency. When you're ready to withdraw your money, Stack will sell your coins and deposit the cash into your bank account. For the user, this process requires little to no effort but allows them to become involved with and reap the benefits of cryptocurrency. Stack is doing a rolling launch this month. To learn more and join the waitlist, visit thestackapp.com.
Paul Snow, CEO, and Co-Founder of Factom sat down with us at the Bitcoin, Ethereum & Blockchain Superconference 2018 to offer his insight on what the blockchain is capable of today and what it may be able to do down the line. Factom, is a blockchain technology company focused on data management and security. The key is that the protocol is built on top of the Bitcoin blockchain, meaning it is decentralized and not run by any one person. This makes it impermeable to being shut down or hacked. Factom's focus is on developing software making it impossible to change the past, making it very beneficial for individuals and businesses who seek a way to make data verifiable and unchangeable. "We see a future world where fraud, corruption, and forgery are a thing of the past. We believe in keeping private data private and securing the world's wealth because privacy and possession of property are basic human rights … Factom
Marco Abele is the founder and CEO of TEND, a platform that will allow its users to invest in and have access to a variety of items, such as collectible cars, vineyards, and jewelry. Based on the interests of their customers and using blockchain technology, TEND will create certificates for popular items and allow for them to be co-owned in the form of digital tokens via smart contracts. For example, rather than spending the money to buy an expensive collectible car outright, a user can find people who are mutually interested in that car, enter a token-based co-ownership agreement with them, and start receiving access to and the proceeds of the appreciation of that car. TEND is not even a year old but has already developed a digital interface on which unique items can be managed, and plans to launch the platform this April to a select 100 customers in Switzerland. By the end of next year, they plan on entering the international market. Tune in to learn more, and visit www.tend.swiss for the latest updates.
Our TOPPODCAST Picks 
